Through TGR5 signaling, the generation of vasodilatory and inhibition of vasoconstrictor molecules serves to modulate liver microcirculation, mitigate portal hypertension and enable adaptation of hepatic blood flow to nutrient uptake [45,47]. The gene discussed is GPBAR1; the disease is liver disorder.